These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 8371712
1. Enhanced stimulation by ribavirin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of purine 2'-beta-fluoro-2',3'-dideoxynucleosides. Johns DG, Ahluwalia GS, Cooney DA, Mitsuya H, Driscoll JS. Mol Pharmacol; 1993 Sep; 44(3):519-23. PubMed ID: 8371712 [Abstract] [Full Text] [Related]
8. Metabolic pathways for the activation of the antiretroviral agent 2',3'-dideoxyadenosine in human lymphoid cells. Johnson MA, Ahluwalia G, Connelly MC, Cooney DA, Broder S, Johns DG, Fridland A. J Biol Chem; 1988 Oct 25; 263(30):15354-7. PubMed ID: 3262616 [Abstract] [Full Text] [Related]
9. Substrate specificity of human deoxycytidine kinase toward antiviral 2',3'-dideoxynucleoside analogs. Kierdaszuk B, Bohman C, Ullman B, Eriksson S. Biochem Pharmacol; 1992 Jan 22; 43(2):197-206. PubMed ID: 1739408 [Abstract] [Full Text] [Related]
10. Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro. Baba M, Pauwels R, Balzarini J, Herdewijn P, De Clercq E, Desmyter J. Antimicrob Agents Chemother; 1987 Oct 22; 31(10):1613-7. PubMed ID: 3435108 [Abstract] [Full Text] [Related]
11. Novel 6-alkoxypurine 2',3'-dideoxynucleosides as inhibitors of the cytopathic effect of the human immunodeficiency virus. Burns CL, St Clair MH, Frick LW, Spector T, Averett DR, English ML, Holmes TJ, Krenitsky TA, Koszalka GW. J Med Chem; 1993 Feb 05; 36(3):378-84. PubMed ID: 8426365 [Abstract] [Full Text] [Related]
13. Role of altered metabolism in dideoxynucleoside pharmacokinetics. Studies of 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats. Singhal D, Morgan ME, Anderson BD. Drug Metab Dispos; 1996 Oct 05; 24(10):1155-61. PubMed ID: 8894519 [Abstract] [Full Text] [Related]
15. Potent and selective activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside, 3'-fluoro-2,6-diaminopurine-2',3'-dideoxyriboside, and 3'-fluoro-2',3'-dideoxyguanosine against human immunodeficiency virus. Balzarini J, Baba M, Pauwels R, Herdewijn P, Wood SG, Robins MJ, de Clercq E. Mol Pharmacol; 1988 Mar 05; 33(3):243-9. PubMed ID: 3258404 [Abstract] [Full Text] [Related]
16. Effect of anti-HIV 2'-beta-fluoro-2',3'-dideoxynucleoside analogs on the cellular content of mitochondrial DNA and on lactate production. Tsai CH, Doong SL, Johns DG, Driscoll JS, Cheng YC. Biochem Pharmacol; 1994 Oct 07; 48(7):1477-81. PubMed ID: 7945448 [Abstract] [Full Text] [Related]
17. Role of brain tissue localized purine metabolizing enzymes in the central nervous system delivery of anti-HIV agents 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats. Singhal D, Morgan ME, Anderson BD. Pharm Res; 1997 Jun 07; 14(6):786-92. PubMed ID: 9210198 [Abstract] [Full Text] [Related]
19. Lipophilic halogenated congeners of 2',3'-dideoxypurine nucleosides active against human immunodeficiency virus in vitro. Shirasaka T, Murakami K, Ford H, Kelley JA, Yoshioka H, Kojima E, Aoki S, Broder S, Mitsuya H. Proc Natl Acad Sci U S A; 1990 Dec 07; 87(23):9426-30. PubMed ID: 2251284 [Abstract] [Full Text] [Related]